InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Kollender Richard S, Chief Financial Officer. Director active across 3 companies, notably Strongbridge Biopharma plc. Aggregated, 14 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €46k. History available since 17 May 2021. The latest transaction was filed on 6 August 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
65,000 shares@ US$0.771283.4% of flowClass A Common StockSEC:0001380106-24-000175:0
Ideal exit: 3 May 2025 (T+270)
14,300 shares0Class A Common StockSEC:0001380106-24-000144:0
234,229 sharesOrdinary SharesSEC:0001179110-21-009284:0
234,229 sharesOrdinary SharesSEC:0001179110-21-009284
64,791 shares@ US$2.0668.3% of flowOrdinary SharesSEC:0001179110-21-009228:0
64,791 shares@ US$2.0668.3% of flowOrdinary SharesSEC:0001179110-21-009228
107,816 shares@ US$0.050.0048% mcap50.0% of flowClass A Common StockSEC:0001104659-21-115207:0
107,816 shares@ US$0.058.3% of flowClass A Common StockSEC:0001104659-21-115207
17,088 shares@ US$2.2419.1% of flowOrdinary SharesSEC:0001179110-21-008673:0
17,088 shares@ US$2.2419.1% of flowOrdinary SharesSEC:0001179110-21-008673
1,315,084 sharesClass A Common StockSEC:0001104659-21-094111
1,315,084 sharesClass A Common StockSEC:0001104659-21-094111:0
11,392 shares@ US$2.2812.6% of flowOrdinary SharesSEC:0001179110-21-005554
11,392 shares@ US$2.2812.6% of flowOrdinary SharesSEC:0001179110-21-005554:0
14 of 14 declarations
About Kollender Richard S
Richard S. Kollender is President and CFO of Strongbridge Biopharma plc and RAPID MICRO BIOSYSTEMS, INC. In these roles, he is responsible for financial management and strategic leadership of both companies. Richard plays a key role in developing financial strategies that support growth and profitability.
